Position in IQV
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$220,077
-$1,980,230 QoQ
Shares Held
1,139
-91.2% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#810
of 1,077 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in IQV Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026New Age Alpha Advisors, LLC holds $6,105,851 across 10 Diagnostics & Research names. IQV ranks #5 (3.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MEDP |
Medpace Holdings, Inc.
|
4,784 | $2,533,558 | |
| 2 | IDXX |
Idexx Laboratories Inc /De
|
3,340 | $1,758,309 | |
| 3 | TMO |
Thermo Fisher Scientific Inc.
|
1,254 | $628,705 | |
| 4 | DHR |
Danaher Corp /De/
|
2,465 | $469,533 | |
| 5 | IQV |
Iqvia Holdings Inc.
This page
|
1,139 | $220,077 | |
| 6 | VCYT |
Veracyte, Inc.
|
3,681 | $216,185 | |
| 7 | RDNT |
RadNet, Inc.
|
2,121 | $130,802 | |
| 8 | WAT |
Waters Corp /De/
|
253 | $94,885 |
All Filings in IQV
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $220,077 | 1,139 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $2,200,307 | 12,902 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $3,003,588 | 13,325 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $3,432,215 | 18,070 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $2,887,836 | 18,325 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $3,345,116 | 18,974 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $4,564,534 | 23,228 | Shares | Sole | 2025-02-12 | |
| No filing history on record for this holder in this stock. | ||||||